Evaluation of the efficacy of a combined formulation (Grippostad®-C) in the therapy of symptoms of common cold: a randomized, double-blind, multicenter trial

Abstract

The efficacy of Grippostad-C for the treatment of common cold was proven. The findings demonstrate that the combination is superior to each of its separate components and each of the components has its own distinctive contribution to the efficacy of the combination product.